Show simple item record

dc.contributor.authorJimenez-Fonseca, P
dc.contributor.authorCarmona-Bayonas, A
dc.contributor.authorLamarca, Angela
dc.contributor.authorBarriuso, Jorge
dc.contributor.authorCastano, A
dc.contributor.authorHernando, J
dc.contributor.authorLopez, C
dc.contributor.authorMarazuela, M
dc.contributor.authorCrespo, G
dc.contributor.authorEscudero, P
dc.contributor.authorCapdevila, J
dc.contributor.authorCarbonero, RG
dc.date.accessioned2020-06-15T12:57:38Z
dc.date.available2020-06-15T12:57:38Z
dc.date.issued2020en
dc.identifier.citationJimenez-Fonseca P, Carmona-Bayonas A, Lamarca A, Barriuso J, Castano A, Hernando J, et al. Progression-free survival as a surrogate endpoint in gastroenteropancreatic neuroendocrine tumors treated with somatostatin analogues. Neuroendocrinology. 2020;110:230-en
dc.identifier.urihttp://hdl.handle.net/10541/622969
dc.language.isoenen
dc.titleProgression-free survival as a surrogate endpoint in gastroenteropancreatic neuroendocrine tumors treated with somatostatin analoguesen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentHospital Universitario Central de Asturias, Oviedo, Spainen
dc.identifier.journalNeuroendocrinologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record